Treat or Palliate: Outcomes of Very Elderly Myeloma Patients

Overview

Journal Haematologica

Specialty Hematology

Date 2017 Oct 14

PMID 29025911

Citations 5

Authors

Fotios Panitsas

Jaimal Kothari

Grant Vallance

Faouzi Djebbari

Lisa Ferguson

Manuela Sultanova

Karthik Ramasamy

Affiliations

Soon will be listed here.

Citing Articles

The characteristics of Korean elderly multiple myeloma patients aged 80 years or over.

Lee S, Cho H, Moon J, Jung J, Kim M, Heo M Korean J Intern Med. 2025; 40(1):115-123.

PMID: 39778530 PMC: 11725474. DOI: 10.3904/kjim.2024.041.

Daratumumab Treatment for "Truly Frail" Elderly Myeloma Patients.

Horigome Y, Suzuki K, Suzuki T Life (Basel). 2024; 14(3).

PMID: 38541713 PMC: 10971975. DOI: 10.3390/life14030389.

Difficult-to-treat patients with relapsed/refractory multiple myeloma: A review of clinical trial results.

Raab M, Zamagni E, Manier S, Rodriguez-Otero P, Schjesvold F, Broijl A EJHaem. 2023; 4(4):1117-1131.

PMID: 38024633 PMC: 10660429. DOI: 10.1002/jha2.743.

Multiple Myeloma in Patients over 80: A Real World Retrospective Study of First Line Conservative Approach with Bortezomib Dexamethasone Doublet Therapy and Mini-Review of Literature.

Huynh L, Birsen R, Mora L, Couderc A, Mitha N, Farcet A Cancers (Basel). 2022; 14(19).

PMID: 36230662 PMC: 9564122. DOI: 10.3390/cancers14194741.

Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect MM Registry.

Lee H, Ailawadhi S, Gasparetto C, Jagannath S, Rifkin R, Durie B Blood Cancer J. 2021; 11(7):134.

PMID: 34301916 PMC: 8302734. DOI: 10.1038/s41408-021-00524-1.

References

Murthy V, Krumholz H, Gross C . Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004; 291(22):2720-6. DOI: 10.1001/jama.291.22.2720. View

Palumbo A, Bringhen S, Mateos M, Larocca A, Facon T, Kumar S . Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report. Blood. 2015; 125(13):2068-74. PMC: 4375104. DOI: 10.1182/blood-2014-12-615187. View

Dimopoulos M, Kastritis E, Delimpasi S, Katodritou E, Hatzimichael E, Kyrtsonis M . Multiple myeloma in octogenarians: clinical features and outcome in the novel agent era. Eur J Haematol. 2012; 89(1):10-5. DOI: 10.1111/j.1600-0609.2012.01784.x. View

Matsue K, Matsue Y, Fujisawa M, Fukumoto K, Suehara Y, Sugihara H . Clinical features and treatment outcome of very elderly patients over 80 years old with multiple myeloma: comparison with patients in different age groups in the era of novel agents. Leuk Lymphoma. 2015; 57(1):110-5. DOI: 10.3109/10428194.2015.1041386. View

Willan J, Eyre T, Sharpley F, Watson C, King A, Ramasamy K . Multiple myeloma in the very elderly patient: challenges and solutions. Clin Interv Aging. 2016; 11:423-35. PMC: 4839967. DOI: 10.2147/CIA.S89465. View

Niesvizky R, Flinn I, Rifkin R, Gabrail N, Charu V, Clowney B . Community-Based Phase IIIB Trial of Three UPFRONT Bortezomib-Based Myeloma Regimens. J Clin Oncol. 2015; 33(33):3921-9. DOI: 10.1200/JCO.2014.58.7618. View

Kanda Y . Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2012; 48(3):452-8. PMC: 3590441. DOI: 10.1038/bmt.2012.244. View

Benboubker L, Dimopoulos M, Dispenzieri A, Catalano J, Belch A, Cavo M . Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma. N Engl J Med. 2014; 371(10):906-17. DOI: 10.1056/NEJMoa1402551. View

Turesson I, Velez R, Kristinsson S, Landgren O . Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic. Mayo Clin Proc. 2010; 85(3):225-30. PMC: 2843108. DOI: 10.4065/mcp.2009.0426. View

10.

Tuchman S, Shapiro G, Ershler W, Badros A, Cohen H, Dispenzieri A . Multiple myeloma in the very old: an IASIA conference report. J Natl Cancer Inst. 2014; 106(5). PMC: 4580557. DOI: 10.1093/jnci/dju067. View

11.

Kumar S, Dispenzieri A, Lacy M, Gertz M, Buadi F, Pandey S . Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia. 2013; 28(5):1122-8. PMC: 4000285. DOI: 10.1038/leu.2013.313. View

12.

Kumar S, Rajkumar S, Dispenzieri A, Lacy M, Hayman S, Buadi F . Improved survival in multiple myeloma and the impact of novel therapies. Blood. 2007; 111(5):2516-20. PMC: 2254544. DOI: 10.1182/blood-2007-10-116129. View